Papers

2

Total Citations

54

H-Index

2

About

Claudius Jelgersma is a leading researcher in the field of neuro-oncology and stereotactic radiosurgery, with a specific focus on the treatment of meningiomas. His major contributions center on advancing the precision and efficacy of robotic radiosurgery, particularly through the integration of advanced imaging modalities. Notably, his work demonstrates how 68Ga-DOTATOC PET/MRI can significantly improve treatment planning for meningioma patients, enhancing the delineation of tumor boundaries and critical structures, which is especially crucial for complex skull base lesions and post-surgical cases. This research, published in 2019 and cited 31 times, has provided a foundational framework for more accurate and safer radiosurgical interventions. Additionally, his study on image-guided robotic radiosurgery for recurrent grade II and III meningiomas, with 23 citations, offers critical insights into managing aggressive, high-grade tumors. Jelgersma’s work is instrumental in refining non-invasive treatment strategies, directly impacting clinical outcomes and patient quality of life. His achievements underscore a commitment to translating cutting-edge imaging and technology into tangible therapeutic advancements, making him a notable figure in the evolution of precision radiotherapy.

Research Focus

Key Achievements

2
H-Index
2
Papers
54
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution
31 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago